Conversations
Spider Silk for Heart Valves with PrintyMed’s Jekaterina Romanova
Jekaterina Romanova is the CEO of PrintyMed, a biomedical startup making artificial spider silk for 3D bioprinting and medical devices.
Conversations
Jekaterina Romanova is the CEO of PrintyMed, a biomedical startup making artificial spider silk for 3D bioprinting and medical devices.
Conversations
Ross Youngs is the founder and CEO of Biosortia, the only company practicing Microbiome Mining.
Conversations
Ulrike Pfreundt is the co-founder of rrreefs, a startup rebuilding coral reefs through 3D printing.
Newsletters
Plus: SpaceX launches Starship and brings it back, the Thousand Brains project, an LLM runs for mayor in Wyoming, new night vision technology, and more.
Conversations
Reilly Brennan is the founding partner at Trucks Venture Capital, a firm funding the entrepreneurs building the future of transportation.
Newsletters
Plus: 3D-printed rocket test, China's $47B chip sovereignty fund, red tape strangling wind farms, three ingredient battery, and more.
Conversations
Hal Hinkle is the CEO of BamCore, a company building high-performance beyond zero carbon footprint framing systems for buildings.
The most widely read newsletter in deep tech. Get exclusive interviews, deals, and news from the frontier in your inbox. Every Friday.
Plus: Avalanche's desktop fusion reactor, NASA's X-59 goes supersonic, NY lawmakers pass first in US data center moratorium, China's big bet on big nuclear reactors, and more.
Viktor Shpakovsky is an investment partner at Beyond Earth Ventures, a $30 million venture capital fund investing in transformative deep tech across space tech, robotics, energy, and compute.
Plus: Agtech investment is booming, SpaceX outlines plans for Starfall re-entry vehicles, AI executives call for stricter regulations on synthetic biology, the people who want AI to replace humanity, and more.
Brian Wilcove is the managing director of America's Frontier Fund (AFF), a sovereign-aligned venture capital firm investing in frontier technologies to strengthen U.S. innovation and economic competitiveness.
Plus: Blue Origin's mega-rocket explodes, race to mine the deep sea, IBM's first pure-play quantum chip foundry, NASA selects companies for moon base awards, and more.
Plus: Biomanufacturing to reshape organ transplants, grid batteries are booming, quantum's make-or-break moment, growing chickens in 3D printed eggs, Japan sells out of robot wolves, in-space refueling demo, and more.
Plus: Helium-3 lunar gold rush, Virgin Galactic to begin commercial service, Cowboy files for 20k orbital data centers, non-viral gene therapy, real life gundams, and more.
Plus: China opens rocket launches to international satellites, the future of IVF, a geothermal IPO, big tech targets drug discovery, DARPA eyes commercial space boom, and more.
Plus: Pentagon's drone spending spree, air taxis come to NYC, Zuck's virtual biology initiative, DeepSeek's new model, FDA wants to accelerate clinical trails with AI, and more.
Plus: New Glenn suffers upper stage malfunction, China ramps up satellite capacity, cracks in fusion's funding boom, robot marathon, slime-like artificial muscles, cocaine-fueled salmon, and more.
Paul Veugen is co-founder and partner at NP-Hard Ventures, an Amsterdam-based early-stage venture capital firm investing in pre-seed and seed companies solving the hardest problems across robotics, defense tech, and foundational infrastructure.
Plus: nuclear reactors on the moon, implantable pharmacies, 3D printing batteries, first complete human genome loaded onto quantum computer, Science Corp gets ready for brain implant, ARPA-E doubles down on fusion, and more.